• Open Access

Omeprazole in a Dog With Gastrinoma

Authors

  • Dana Brooks,

    Corresponding author
    1. Department of Small Animal Clinical Sciences, Michigan State University Veterinary Teaching Hospital, East Lansing, MI.
      DVM, Towne and Country Veterinary Hospital, 8 Caton Road, Corning, NY 14830.
    Search for more papers by this author
  • Gary L. Watson

    1. Department of Small Animal Clinical Sciences, Michigan State University Veterinary Teaching Hospital, East Lansing, MI.
    Search for more papers by this author

DVM, Towne and Country Veterinary Hospital, 8 Caton Road, Corning, NY 14830.

Abstract

A 9-year-old male German Shepherd Dog was presented with the primary complaints of vomiting, profuse watery diarrhea, anorexia, and severe weight loss. The dog developed hematemesis and melena, which were unresponsive to treatment with an H2-receptor antagonist and a gastrointestinal protectant. A marked neutrophilia, panhypoproteinemia, hypokalemia, and mildly increased activities of alkaline phosphatase and alanine aminotransferase were the only relevant abnormalities found on a CBC, serum biochemical profile, and urinalysis. An exploratory laparotomy revealed several small nonresectable masses at the root of the mesentery, which were identified histologically as a neuroendocrine neoplasm. Immunohistochemical staining of the neoplasm was positive for gastrin and negative for insulin, glucagon, pancreatic polypeptide, and vasoactive intestinal polypeptide. Fasting serum gastrin concentrations were high. Zollinger-Ellison syndrome was diagnosed, and the dog was treated with omeprazole, an H+, K+-ATPase inhibitor. All clinical signs resolved, and the dog remains asymptomatic 2 years later. Omeprazole may be the gastric acid antisecretory drug of choice for dogs with gastrinoma.

Ancillary